• 中国核心期刊数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2024, Vol. 26 ›› Issue (8): 804-807.

• 临床医药 • 上一篇    下一篇

结核丸辅助常规四联抗结核治疗继发肺结核的疗效观察

姜歆蕾, 宋戎*   

  1. 镇江市第三人民医院,江苏 镇江 212001
  • 收稿日期:2024-09-25 修回日期:2024-09-29 出版日期:2024-08-28 发布日期:2024-08-28
  • 基金资助:
    镇江市社会发展指导性项目(FZ2015035)

The Efficacy of Tuberculosis Pill Adjuvant to Conventional Quadruple Anti-tuberculosis Therapy in the Treatment of Secondary Pulmonary Tuberculosis

  1. The Third People's Hospital of Zhenjiang Jiangsu Zhenjiang 212001, China
  • Received:2024-09-25 Revised:2024-09-29 Online:2024-08-28 Published:2024-08-28

摘要:

目的:探究结核丸辅助常规四联抗结核治疗继发肺结核疗效、安全性及对肺功能的影响。方法:选取2021 1月至202312月我院收治的207例继发肺结核患者作为研究对象,依据随机数字分成两组,观察组(n=104)和常规组(n=103)。常规组患者单纯采用常规四联抗结核的方式治疗,观察组患者在使用常规四联抗结核的治疗基础上联合服用结核丸。两组患者均治疗6个月。比较两组患者不同治疗方案的疗效(治疗总有效率、空洞闭合率);比较两组患者不良反应发生率;比较两组患者的肺功能(FEV1FEV1/FVC)。结果:观察组患者的治疗总有效率达到98.08%,高于常规组的89.32%P<0.05)。观察组患者空洞闭合改善率(92.31%)大于常规组的75.73%P<0.05)。观察组患者的不良反应发生率(6.73%)低于常规组的26.21%P<0.05)。两组患者治疗前肺功能指标差异无统计学意义(P>0.05)。相比于治疗前,两组患者治疗6个月后的FEV1FEV1/FVC数值均增大,且观察组患者FEV1FEV1/FVC数值增高幅度大于常规组(P<0.05)。结论:结核丸辅助常规四联抗结核治疗继发肺结核具有显著的疗效和安全性,并且能在一定程度上改善肺功能,可为临床诊断及治疗提供参考价值。


关键词:  , 继发肺结核;结核丸;常规四联抗结核;疗效;安全性;肺功能

Abstract:

Objective: To explore the efficacy safety and impact on lung function of tuberculosis pill adjunct to conventional quadruple anti-tuberculosis therapy in the treatment of secondary pulmonary tuberculosis.Methods: 207 patients with secondary pulmonary tuberculosis who were admitted to our hospital during the period from January 2021 to December 2023 were selected as the research objects. These patients were randomly allocated into two groups the observation group consisting of 104 cases and the conventional group with 103 cases. The conventional group was treated with conventional quadruple anti-tuberculosis therapy alone while the observation group was treated with tuberculosis pill in combination with conventional quadruple anti-tuberculosis therapy. Both groups of patients were treated for 6 months.The curative effect the total efficiency rate of treatment cavity closure rate was compared between the two groups. The occurrence rate of adverse reactions was compared between the two groups. The effects of different drug regimens on lung function FEV1FEV1/FVCwere compared between the two groups.Results: The total efficiency rate of treatment among patients in the observation group stood at 98.08% marking a substantial increase compared to the 89.32% rate observed in the conventional groupP<0.05. The rate of cavity closure improvement in the observation group apparently outperformed the conventional group standing at 92.31% compared to 75.73% P<0.05. The observation group exhibited a notably lower occurrence rate of adverse reactions 6.73% vs 26.21%) (P<0.05. There was no statistic difference in lung function indicators between the two groups of patients before treatment P>0.05. After 6 months of treatment the FEV1 and FEV1/FVC values of the two groups of patients apparently increased compared to those before treatment and the FEV1 and FEV1/FVC values in the observation group were higher than those in the control group P<0.05.Conclusion: The use of tuberculosis pill adjunct to conventional quadruple anti-tuberculosis therapy treatment of secondary pulmonary tuberculosis has significant efficacy and safety and can improve lung function to a certain extent providing reference value for clinical diagnosis and treatment.


Key words: Secondary pulmonary tuberculosis , Tuberculosis pill , Conventional quadruple anti-tuberculosis therapy , Efficacy , Safety , Lung function

中图分类号: